Anivive Lifesciences Welcomes Former Speaker Kevin McCarthy to Board as It Prepares Groundbreaking Valley Fever Vaccine

Anivive Lifesciences appoints Kevin McCarthy to its Board, supporting the development of the first Valley Fever vaccine for pets. With a targeted 2025 launch, the vaccine aims to protect millions of dogs and zoo animals affected by the disease. #ValleyFeverVaccine #AniviveLifesciences #KevinMcCarthy